Company intelligence / Profile preview

Knack

Fair Lawn, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Knack Pharmaceuticals is a global pharmaceutical company focused on the manufacturing and marketing of injectable products for hospital use. Headquartered in New Jersey, the company operates a commercial infrastructure for generic drugs and provides high-quality medicines at accessible price points. Beyond its generic portfolio, Knack offers contract development and manufacturing (CDMO) services, specializing in sterile liquid formulations, solid-state characterization, and the production of biologics, proteins, and peptides. The company aims to be a benchmark in the U.S. pharmaceutical industry through innovation and strategic partnerships with healthcare stakeholders.

Therapeutic areas: Other
Modalities: BiologicProteinPeptidesSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Knack.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Knack.

Explore the full profile